Review on the Kampo Treatment and Education Program for Children with Developmental Disabilities in Japan

일본에서 발달장애아를 대상으로 Kampo치료 및 교육프로그램의 제공에 대한 연구동향

  • Kim, Mi-Suk (Special Education, Teachers College, Baekseok University) ;
  • Ko, Byoung Seob (Herbal Medicine Research Division, Korea Institute of Oriental Medicine (KIOM))
  • 김미숙 (백석대학교 사범학부 특수교육과) ;
  • 고병섭 (한국한의학연구원 한약연구부)
  • Received : 2019.10.24
  • Accepted : 2019.11.19
  • Published : 2019.11.30


Objectives This study reviewed the effects of a combined treatment with Kampo and Western medicine for Developmental disability in Japan, and the provision of education programs in clinical care. Methods The search database includes J-STAGE. To narrow the search, the following key words were used: 'pervasive developmental disorders, Attention-Deficit/Hyperactivity Disorder, Learning Disorders or Learning Disabilities, Intellectual Disability, and Kampo'. The search was limited to the publication date from 2001 to 2019. Results 1. Japan analyzed five sections: The usage of the Kampo medicine ranges from 25.2% to 71.6%, and the Kampo medicine was highly used in large cities. 2. In Japan, the educational programs were provided for the caregiver and special educational programs were available for children with disabilities. 3. In Japan, there were 9 studies regarding developmental disability treating with herbal remedies. There were seven clinical trial reports, and two were published in a review or report form. 4. The results showed benefits of using Kampo for patients with lack of Yin in blood in treatment of developmental disorder. It is also important to control the liver qi and Yin in blood. 5. Seven papers reported no side effects or abnormal findings. They have reduced the use of antipsychotics. Conclusions These review studies in regards to the combined treatment of Kampo and Western medicines can be helpful to improve long term side effects of the antipsychotics used in developmental disorders.


Supported by : 백석대학교


  1. National Rehabilitation Center for Persons with Disabilities (Japan), Information and support center for persons with developmental disorders, 'Do you have concerns about your child's development?', Available from:
  2. Hee Jung Chung, Developmental Disabilities in Children, Korean Journal of Pediatrics, 2004;47(2):131-39
  3. Y Tokunaga, Support for persons with developmental disabilities in Japan, National Institute of Special Education(NISE), Journal of Special Education in the Asia Pacific, 2005;41-43.
  4. Y Inoue, Yasuyuki Okamura, Junichi Fujita, Psychotropic prescribing practices for children and adolescents with intellectual disabilities : A cohort study using a large-scale health insurance database, Psychiat. neurol. Jap, 2016;118(11):823-33.
  5. K. Yamada, Quality of life in patients treated with Kampo medicine: a complementary alternative to modern medicine, J Altern Complement Med. 2006;12(8):799-803.
  6. S Nishida, T Nishimoto, K Yasuda, A Koyama, Effectiveness of tokaku-joki-to and Kam-baku-taiso-to for Autistic Patient's Impulse - Report of a case, Journal of Japanese Association of Oriental Psychosomatic Medicine, 2004;19(1):2.
  7. H Hiraiwa, R Hiraiwa, S Date, T Sakiyama, Muscle hypertension excitation, and insomnia, possibly related with the administration of Bupleurum Root containing formulations, for 7cases of severe mental and physical disabilities, or developmental disorder, Kampo Med, 2010;61(1):36-44.
  8. Y Nakagawa, Renewed thoughts on what is being required of kampo - Form some memorable cases, Kampo Med, 2011;62(1):70-80.
  9. H Takehara, Y Matsukawa, Y Tanaka, S Yamamoto, R Horitani, F Nishimori, Two cases sleep disorder with developmental disorders successfully treated with Kampo medicines, Kampo Med, 2018;69(3):246-51.
  10. T Sugiyama, A brief Trauma Therapy for Complex PTSD, Jpn J Psychosom Med, 2019;59:219-24.
  11. H Koike, Y Horiba, K Watanabe, A case of involuntary movements treated with YakukansankashakuyakukoboKu, Kampo Med, 2016;76(2):178-83.
  12. Y Ohtomo, S Fujinaga, N Nishizaki, Current medical treatment for monosymptomatic nocturnal enuresis, Japanese Journal of Pediatric Nephrology, 2016;29(2):34-41.
  13. M Kodama, R Izumi, K Masagi, K Inoguchi, Experience using Kam-baku-taiso-to for children with severe mental and physical disabilities that show insomnia, unrest, tension, etc., Journal of Severe Motor and Intellectual Disabilities, 2017;42(2):172.
  14. K Hirabayashi, H Sato, M Sato, J Tamura, A case of child anxiety disorder with orthostatic dysregulation successfully treated with Ogikenchuto in combination with western medicine, Kampo Med, 2017;68(4):362-65.
  15. World Health Organization(WHO), International Classification of Diseases ICD-10, Available from:
  16. N. Haglund, SO. Dahlgren, P. Gustafsson, M. Rastam, and K. Kallen, Early screening for autism in child health care services, Austin Journal of Autism & Related Disabilities, 2017;3(1):1038-45.
  17. G.J. DuPaul, T.J. Power, K.E. McGoey, M.J. Ikeda, A.D. Anastopoulos, Reliability and validity of parent and teacher ratings of Attention-Deficit/Hyperactivity Disorder, symptoms, Journal of Psychoeducational Assessment, 1998;16:55-68.
  18. Rie Wakimizu, Quantitative and qualitative consideration on the eects of parenting program on children with a Developmental Disability, parents, families who have regular visit to hospital, 2016;21(2):158-69
  19. Ministry of Health, Labour and Welfare, Measures to Support Developmentally Disabled Persons(Japanese), Available from:
  20. Yosho KASE, Front line - The latest evidence of Chinese herbal medicine and future developments(Article in Japanese), Pharmaceutical Society of Japan, 2011;47(5):392-396.
  21. Seol Gae(薛鎧).Seol Gi(薛己), Chinese Text Project. Boyeongchwalyo (保嬰撮要). 2016. Available at: URL: Accessed August 15, 2018.
  22. K. Yamada, S. Aoyama, Application Yokukansan, Kampo Med, 2011;62(3):479-508.
  23. Ichiro WATANABE, Clinical Effects of Tokaku-joki-to (Tao-He-Cheng-Qi-Tang) Extract, Nihon Toyo Igaku Zasshi (Japanese Journal of Oriental Medicine), 1995;45:557-61.
  24. M. Naseri, M. Hiradfar, Monosymptomatic and non-monosymptomatic nocturnal enuresis: a clinical evaluation, Arch Iran Med. 2012;15(11):702-6.
  25. Ohtomo Y, Umino D, Niijima S, Fujinaga S, Shimizu T, Yokukansan: A Treatment Option for Nocturnal Enuresis in Children by Improving Sleep Quality, Juntendo Medical Journal, 2015;60:536-542.
  26. Kaori Kubota, Ai Nogami, Kotaro Takasaki, Shutaro Katsurabayashi, Kenichi Mishima, Michihiro Fujiwara, Katsunori Iwasaki, Pharmacological study on the ameliorative effects of Yokukansan on the memory impairment and the behavioral and psychological symptoms of dementia in AD models, Folia Pharmacol. Jpn., 2014;143:110-4.
  27. Masanaga Yamawaki, Education of Japanese traditional medicine: Educational Program in Kyoto Prefectural University of Medicine, Journal of Kyoto Prefectural University of Medicine, 2016;125(2):107-114.
  28. T. Oka, M. Ashihara, T. Ito, S. Nishida, M. Murakami, The Prevalence of Psychotropic Drugs and Kampo medicine combination therapies in japan, journal of Japanese Association of Oriental Psychosomatic Medicine, 2007;22(1/2):97-102.